Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Title Grant Type Focus Area Country Application Due Date Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career InvestigatorsRelease Date:Research Inflammation & Immunology USA Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established InvestigatorsRelease Date:Research Inflammation & Immunology USA 2022 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Innovative Digital Health Projects in OncologyRelease Date:Quality Improvement Oncology Italy BRAF V600-mutant colorectal cancer: disease education and therapy managementEducation Oncology USA Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in CanadaRelease Date:Quality Improvement Rare Disease Canada Heart Failure and Cardiomyopathy Leading to Differential Diagnoses of Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Establish a System to Refer Patients with Suspected CardiomyopathyRelease Date:Quality Improvement Rare Disease Japan Improving the care of patients living with metastatic breast cancer (mBC)Quality Improvement Oncology Canada Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access DisparitiesQuality Improvement Hospital All Promotion of Smoking Cessation Treatment in General PracticeRelease Date:Education Internal Medicine Japan Global ATTR Amyloidosis ResearchRelease Date:Research Rare Disease All